GLOBAL RESEARCH ARCHIVE
SM Entertainment: 2Q26 in-line; not many catalysts for 3Q26
Research evidence excerpt
M
Update
August 5, 2026 08:52 AM GMT
Morgan Stanley & Co. International plc, Seoul Branch+
SM Entertainment | Asia Pacific
Jenna Lee
Equity Analyst
2Q26 in-line; not many catalysts
for 3Q26
AlphaSignals Earnings Reaction
SM Entertainment (041510.KQ, 041510 KS)
Unchanged
In-line
Largely unchanged
Impact to our thesis
Financial results versus consensus
Direction of next 12-month
consensus EPS
S. Korea Media | S. Korea
Stock Rating
Industry View
Price target
Shr price, close (Aug 4, 2026)
52-Week Range
Sh out, dil, curr (mn)
Mkt cap, curr (bn)
EV, curr (bn)
Avg daily trading value (bn)
Source: Company data, Morgan Stanley Research
Key Takeaways
SM posted 2Q26 OP of W53bn (up 1% YoY, up 15% QoQ), in-line with our
estimates and consensus.
Equal-weight
In-Line
W80,000
W76,700
W155,100-63,900
23
W1,799
W1,441
W17
Strong parent MD sales and subsidiary performance led to better-than-expected
top-line results.
But parent GPM was pressured by an unfavorable segment mix (high artist
involvement biz 30% of sales in 2Q26 vs. 26% in 2Q25) and a high legacy IP
contribution.
Consolidated OP improvement was driven by subsidiaries, notably Dream Maker
(concert promotion), but the sustainability of this improvement remains
uncertain.
We expect 3Q26 earnings to decline YoY, given a weaker album and concert
pipeline. Boy band debut should be a key determinant of future share price
performance.
What's next? Key events in 3Q26 will be aespa's world tour in Asia and America
(arena size) and NCT 127's album release. The album and concert pipeline generally
looks weaker YoY, which could lead to an OP decline in 3Q26. The company is
focused on preparations for the boy band debut (SMTR25), planned for 4Q26 or
1Q27. A successful launch of the new group should be a key determinant of future
earnings growth and share price performance.
Exhibit 1:
2Q26 preliminary results
W bn
Total revenue
Parent
-Album
-Streaming
-Appearance
-Concert
-MD/Licensing
Subsidiaries
Gross profit
GPM %
Parent Gross profit
GPM %
SG&A
Operating profit
OPM %
Parent OP
OPM %
Subsidiaries OP
Net profit
2Q25
303
220
72
27
23
34
64
83
115
37.8%
76
34.3%
67
48
15.7%
46
20.8%
2
29
1Q26
279
189
27
31
20
61
47
90
100
36.0%
60
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer